ERRα过度表达对子宫内膜癌Ishikawa细胞内分泌治疗的影响  被引量:1

Over expression of estrogen receptor-related receptor α provide a potential resistant mechanism to endocrine therapy

在线阅读下载全文

作  者:孙蓬明 宋一一 高敏 毛晓丹 赵丽君[3] 林芬 魏丽惠[3] 

机构地区:[1]福建省妇幼保健(妇儿)医院妇科肿瘤研究室,福州350001 [2]北京大学肿瘤医院 [3]北京大学人民医院

出  处:《中国妇产科临床杂志》2012年第2期126-129,共4页Chinese Journal of Clinical Obstetrics and Gynecology

基  金:国家自然科学基金(30600666);福建省科技厅重点资助项目(2008I0011);国家人事部2007年度留学回国人员择优资助课题[国人厅发(2007)170号];福建省高层次人才课题启动基金

摘  要:目的探讨孤儿受体-雌激素受体相关受体α(ERRα)在子宫内膜癌Ishikawa细胞中过度表达对内分泌治疗的影响。方法重组并构建含有绿色荧光蛋白(GFP)和G418耐药筛选标记的真核表达质粒pEGFP-N1-3FLAG-ERRα,瞬时转染子宫内膜癌细胞株Ishikawa后采用实时荧光定量PCR技术和蛋白印迹法检测ERRαmRNA和蛋白的表达情况。使用不同浓度的ICI182780处理子宫内膜癌Ishikawa细胞、Ishikawa-空载体细胞(Ishikawa-空)和ERRα过度表达的(Ishikawa-ERRα)细胞,流式细胞技术检测分析10-6mol/LICI182780对细胞诱导的凋亡情况。结果瞬时转染pEGFP-N1-ERRα质粒后,Ishikawa在mRNA和蛋白水平均能检测到ERRα的表达增加。流式细胞仪细胞凋亡分析表明,ERRα过度表达导致子宫内膜癌细胞Ishikawa耐受ICI182780的诱导凋亡作用(P<0.05)。结论 ERRα过度表达为激素依赖性的子宫内膜癌细胞株Ishikawa提供了一种耐受内分泌治疗的机制。Objective To discuss the function of over-expression of ERRα in endometrial cancer cells and the potential role of ERRα in the resistant mechanism to endocrine therapy.Methods Plasmid pEGFP-N1-3FLAG-ERRα was reconstructed and transiently transfected into endometrial cancer cell Ishikawa.Real-time quantitative PCR and western-blot was used to analyze the mRNA and protein expression of ERRα.After treated with 10-6 mol/L ICI182780,the cellular apoptosis was analyzed in the Ishikawa cells,Ishikawa cells with empty vector(Ishikawa-vector)as well as the cells with ERRα over-expression(Ishikawa-ERRα)by using Annexin V-plus kit and flowcytomertry.Results After transfection,the cell lines were detected an increasing expression of ERRα in mRNA levels and protein levels.In endometrial cancer cells,over-expression of ERRα achieved a resistance to the cell apoptosis induced by high dose of ICI182780(10-6mol/L,pure anti-ER).Conclusions Over-expression of ERRα may provide a molecular mechanism to resist the pure anti-ER endocrine therapy by repressing ER function.ERRα may be the next endocrine therapy target in hormone-related cancer.

关 键 词:子宫内膜癌 雌激素受体相关受体α 内分泌治疗 耐受机制 

分 类 号:R737.33[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象